Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes. [PDF]
Ann MedYi Y, Yang J, Chen Y, Liu H, Deng Y.
europepmc +1 more source
Transcatheter arterial microembolization for refractory chronic pain associated with familial gouty tophi: a case report with 2-year follow-up. [PDF]
CVIR EndovascSugihara E +6 more
europepmc +1 more source
Effects of Citrate Mixture on Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Underexcretion-Type Gout Patients: A Prospective Cohort Study. [PDF]
J Inflamm ResXu L +15 more
europepmc +1 more source
A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri). [PDF]
Sci ProgTsai SF, Wu MJ, Chen CH.
europepmc +1 more source
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]
Nephrology (Carlton)Inoue R +5 more
europepmc +1 more source
Development of a green chemistry based bioanalytical method using response surface methodology to analyze febuxostat and indomethacin in rabbit plasma. [PDF]
Sci RepAnsary A +7 more
europepmc +1 more source
Efficacy and Safety of Sonidegib in the Treatment of Multiple Facial Cutaneous Basal Cell Carcinomas with Chronic Renal Insufficiency: A Case Report. [PDF]
Clin Cosmet Investig DermatolJing W +6 more
europepmc +1 more source
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study. [PDF]
Front PharmacolWang W +5 more
europepmc +1 more source
Advances in the management of gout: From current strategies to emerging therapies. [PDF]
J Int Med ResZhao Q, Dai X.
europepmc +1 more source
Therapeutic Strategies for Hyperuricemia: From Small-Molecule Inhibitors to RNA Therapeutics. [PDF]
ACS Pharmacol Transl SciYu X, Zhang M, Huang Y.
europepmc +1 more source